BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21071307)

  • 1. [Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan)].
    Pár A; Pár G
    Orv Hetil; 2010 Nov; 151(47):1951-5. PubMed ID: 21071307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
    Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
    Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
    Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
    Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
    Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
    J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
    Fabris C; Smirne C; Toniutto P; Colletta C; Rapetti R; Minisini R; Falleti E; Pirisi M
    Clin Biochem; 2006 Apr; 39(4):339-43. PubMed ID: 16487951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
    Deghady A; Abdou A; El-Neanaey WA; Diab I
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".
    Perazzo H; Pais R; Munteanu M; Ngo Y; Monneret D; Imbert-Bismut F; Moussalli J; Lebray P; Benhamou Y; Thabut D; Ratziu V; de Ledhingen V; Poynard T; ;
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):432-9. PubMed ID: 24924901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
    Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
    Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C.
    Wu WP; Chou CT; Chen RC; Lee CW; Lee KW; Wu HK
    PLoS One; 2015; 10(10):e0140068. PubMed ID: 26469342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
    Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
    Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.